Table 2.
1987–1996 | 2003–2009 | p-value interaction | |||
---|---|---|---|---|---|
No Diabetes | Diabetes | No Diabetes | Diabetes | ||
N | 13,152 | 1,673 | 10,415 | 2,297 | |
CHD incidence | |||||
Incidence rate* (95% CI) | 3.9 (3.5, 4.4) | 11.1 (9.3, 13.2) | 2.2 (1.8, 2.7) | 5.4 (4.2, 7.0) | --- |
Model 1† | 1 (ref) | 2.83 (2.29, 3.49) | 1 (ref) | 2.44 (1.78, 3.34) | 0.39 |
Model 2‡ | 1 (ref) | 1.95 (1.56, 2.43) | 1 (ref) | 2.23 (1.60, 3.13) | 0.33 |
Model 3§ | 1 (ref) | 1.99 (1.59, 2.49) | 1 (ref) | 2.39 (1.69, 3.35) | 0.95 |
CHD mortality | |||||
Mortality rate* (95% CI) | 0.8 (0.7, 1.1) | 4.3 (3.2, 5.7) | 0.4 (0.3, 0.6) | 1.3 (0.9, 1.9) | --- |
Model 1† | 1 (ref) | 5.21 (3.58, 7.58) | 1 (ref) | 2.90 (1.73, 4.87) | 0.09 |
Model 2‡ | 1 (ref) | 3.43 (2.30, 5.11) | 1 (ref) | 2.89 (1.66, 5.04) | 0.08 |
Model 3§ | 1 (ref) | 3.45 (2.31, 5.14) | 1 (ref) | 3.21 (1.81, 5.63) | 0.21 |
CHD: coronary heart disease; CI: confidence interval; p-value for interaction of diabetes status and time period
Rates are per 1,000 person-years and adjusted for age, race, and sex
Model 1: adjusted for age, race, and sex
Model 2: adjusted for age, race, sex, high-density lipoprotein cholesterol, systolic blood pressure, antihypertensive medication use, current smoking, and body mass index
Model 3: adjusted for model 2 variables plus lipid-lowering medication use and low-density lipoprotein cholesterol